Long-term evaluation of transvaginal mesh for pelvic organ prolapse
Official title: Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study
Run by Peking Union Medical College Hospital · NCT05938881 · Data updated 2026-11-12
This study follows women who had surgery for pelvic organ prolapse to see how well the treatments work and if there are any long-term problems up to 10 years later.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 53 Years to 75 Years |
| Sex | Women only |
| Enrollment | 336 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 11 sites (Foshan, Guangdong and 10 other locations) |
| Status | Recruiting |
| Started | June 29, 2023 |
| Main results expected | January 12, 2033 |
| Study ends | March 12, 2033 |
| Registry record updated | July 11, 2023 |
| Trial ID | NCT05938881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women who have previously participated in the original randomized controlled trial.
✕Probably not a fit
Patients who did not participate in the previous RCT or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to follow women who previously participated in a randomized controlled trial comparing two surgical techniques for pelvic organ prolapse: the self-cut mesh procedure and the mesh-kit procedure. The focus is on assessing the long-term success and complication rates of these treatments over a period of up to 10 years post-surgery. Participants will be encouraged to engage in annual examinations and telephone surveys to gather comprehensive data on their outcomes. No new interventions will be administered, as this study is solely focused on long-term follow-up of existing participants.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of transvaginal mesh procedures for treating pelvic organ prolapse.
How similar studies have gone: Other studies have explored similar surgical techniques, but this long-term follow-up approach is relatively novel in evaluating the outcomes of transvaginal mesh procedures.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women enrolled in previous RCT study Exclusion Criteria: * Inability to provide informed consent. Informed consent will be obtained prior to each telephone interview and each in-person visit. * Subjects who appear to have cognitive deficits during the in-person visit or site telephone interview will be withdrawn from the study by the study coordinator.
Where it's running
-
Foshan Maternal and Child Health Care Hospital
Foshan, Guangdong, China Recruiting -
The First Affiliated Hospital of Guangdong Medical College
Guangzhou, Guangdong, China Recruiting -
Changsha Maternal and Child Health Care Hospital
Changsha, Hunan, China Recruiting -
The Secong Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting -
Wuxi Maternal and Child Health Care Hospital
Wuxi, Jiangsu, China Recruiting -
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting
Show 5 more locations
-
Shanxi Provincial People's Hosptial
Xi’an, Shanxi, China Recruiting -
Sichuan University West China Second University Hospital
Chengdu, Sichuan, China Recruiting -
the First Affiliated Hosptial of Xinjiang Medical University
Ürümqi, Xiangjiang, China Recruiting -
The People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang, China Recruiting -
Peking Union Medical College Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Lan Zhu
- Email: zhu_julie@sina.com
- Phone: 86-10-69155749
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving Uroflowmetry: Do Pre-Procedure Reminders Help Women Undergoing Urodynamics
This study tests whether sending reminder calls before a urodynamics test helps women with pelvic floor disorders feel more prepared and less anxious, and whether it makes the procedure go more smoothly.
-
Vaginal Vault Support at Hysterectomy
This trial tests a new double-ligament vault suspension during hysterectomy to help prevent vaginal apex prolapse in women undergoing the procedure.
-
Centered Surgery: Preoperative Counseling to Improve Patient Satisfaction
This study will test whether virtual group counseling sessions (shared medical appointments) help adults having pelvic organ prolapse surgery feel more satisfied and better prepared compared with standard individual phone calls.
-
Pelvic floor muscle training with and without hypopressive exercises for women with pelvic organ prolapse
This will test whether adding hypopressive exercises to pelvic floor muscle training helps women aged 45–65 with stage I–II pelvic organ prolapse improve pelvic floor strength, reduce pain during sex, and feel better overall.
-
Wrist activity tracking to guide early recovery after pelvic organ prolapse surgery
This study will try giving women having pelvic organ prolapse surgery either usual postoperative advice or a guided early-exercise plan while tracking activity with a wrist accelerometer to see which group reaches "mostly recovered" sooner.
-
Mesh-free sacrocolpopexy using the VNOTES (transvaginal endoscopic) approach for pelvic organ prolapse
This trial will try mesh-free sacrocolpopexy using the VNOTES transvaginal endoscopic technique in women with stage II or higher pelvic organ prolapse to see if it improves pelvic support, symptoms, and sexual function over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.